Show simple item record

dc.contributor.author Vidales-Braz, Beatris Maria
dc.contributor.author Silva, Naylê Maria Oliveira da
dc.contributor.author Lobato, Rubens Caurio
dc.contributor.author Germano, Fabiana Nunes
dc.contributor.author Mota, Luísa Dias da
dc.contributor.author Barros, Elvino José Guardão
dc.contributor.author Martinez, Ana Maria Barral de
dc.date.accessioned 2016-11-28T17:01:46Z
dc.date.available 2016-11-28T17:01:46Z
dc.date.issued 2015
dc.identifier.citation VIDALES-BRAZ, Beatris Maria; [et al]. Detection of hepatitis C virus in patients with terminal renal disease undergoing dialysis in southern Brazil: prevalence, risk factors, genotypes, and viral load dynamics in hemodialysis patients. Virology Journal, v. 12, p. 1-8, 2015. Disponível em: <http://virologyj.biomedcentral.com/articles/10.1186/s12985-015-0238-z> Acesso em : 26 nov. 2016. pt_BR
dc.identifier.issn 1743-422X
dc.identifier.uri http://repositorio.furg.br/handle/1/6795
dc.description.abstract Hepatitis C (HCV) is a serious public health issue, and it is estimated that 3% of the world’s population is infected. Patients in hemodialysis units have an increased risk for contracting HCV, and high prevalence rates have been found in hemodialysis units around the world. This study is aimed at determining the prevalence of HCV in patients with terminal chronic renal disease (tCRD) who have been submitted to hemodialysis and peritoneal dialysis in southern Brazil to characterize the most prevalent genotypes, the viral load, and possible risk factors and to assess the validity between the ELISA and RT-PCR detection methods. Of 320 patients from three dialysis units, 318 participated in this study. According to the medical records, 55 patients were reactive to HCV, as determined via ELISA. All 318 samples were submitted to RT-PCR and genotyped using an Abbott Realtime® m2000 system. Data obtained through a questionnaire and chemical variables were associated with the HCV. Results: The prevalence of HCV was 18.24% (58), and the concordance between the HCV serology and the RT-PCR was 94%. Three patients were diagnosed to be negative for HCV using the ELISA assay but positive when using RT-PCR. Genotype 1 was the most prevalent (46.7%) genotype, within which subtype 1a was the most frequent (74.1%). One of the risk factors associated with HCV infection was the length of time that the patient had been undergoing hemodialysis treatments (p < 0.001). Additionally, the viral load was found to vary when tested before and after hemodialysis (p < 0.001). Conclusion: The prevalence of HCV in dialysis units continues to remain high, indicating nosocomial contamination. RT-PCR detected the presence of the hepatitis C virus in patients with a non-reactive serology, which highlights the importance of performing molecular tests on dialysis patients. The variation in the viral load in patients submitted to hemodialysis indicates a possible destruction or gripping of viral particles to the dialyzer membrane. pt_BR
dc.language.iso por pt_BR
dc.rights open access pt_BR
dc.title Detection of hepatitis C virus in patients with terminal renal disease undergoing dialysis in southern Brazil: prevalence, risk factors, genotypes, and viral load dynamics in hemodialysis patients pt_BR
dc.type article pt_BR
dc.identifier.doi DOI: 10.1186/s12985-015-0238-z pt_BR


Files in this item

This item appears in the following Collection(s)

:

  • FAMED – Artigos publicados em periódicos
  • Show simple item record